Clinical Trial Update: A Study To Test The Effect Of GW786034 (Pazopanib) On P450 Enzymes [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate the effect of pazopanib (GW786034) on cytochrome P450 enzymes to understand potential drug interactions; the trial has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Carcinoma, Renal Cell | Phase 1 | Status: COMPLETED